YUHSpace

BROWSE

YUHSpace1. College of Medicine (의과대학)Dept. of Pathology (병리학교실)

Dept. of Pathology (병리학교실)

Researcher List

Keyword Cloud

Journal Categories

Highly Cited Articles

Long-term prevention of renal insufficiency, excess matrix gene expressi...

Fuad N. Ziyadeh ; Brenda B. Hoffman ; Dong Cheol Han ; M. Carmen Iglesias-de ... Proceedings of the National Academy of Sciences of the United States of America, Vol.97(14) : 8015-8020, 2000
PDF

Anchored multiplex PCR for targeted next-generation sequencing.

Zongli Zheng ; Matthew Liebers ; Boryana Zhelyazkova ; Yi Cao ; Divya Panditi... NATURE MEDICINE, Vol.20(12) : 1479-1484, 2014

Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtype...

Apinya Jusakul ; Ioana Cutcutache ; Chern Han Yong ; Jing Quan Lim ; Mi Ni Hu... CANCER DISCOVERY, Vol.7(10) : 1116-1135, 2017
PDF
This table browses all dspace content
Issue DateTitleJournal Title
2024Augmented interpretation of HER2, ER, and PR in breast cancer by artificial intelligence analyzer: enhancing interobserver agreement through a reader study of 201 cases BREAST CANCER RESEARCH
202411C-Acetate PET/CT for Reactive Astrogliosis Outperforms 11C-Methionine PET/CT in Glioma Classification and Survival PredictionCLINICAL NUCLEAR MEDICINE
2024Reply to: Comments on "Randomized, two-arm, non-comparative phase 2 study of olaparib plus cediranib or durvalumab in HRR-mutated, platinum-resistant ovarian cancer: A substudy of KGOG 3045INTERNATIONAL JOURNAL OF CANCER
2024Durvalumab plus pazopanib combination in patients with advanced soft tissue sarcomas: a phase II trial NATURE COMMUNICATIONS
2024Trends and Clinical Characteristics of Next-Generation Sequencing-Based Genetic Panel Tests: An Analysis of Korean Nationwide Claims Data CANCER RESEARCH AND TREATMENT
2024Clinical Impact of Genomic and Pathway Alterations in Stage I EGFR-Mutant Lung Adenocarcinoma CANCER RESEARCH AND TREATMENT
2024Diagnosis of Primary Ciliary Dyskinesia via Whole Exome Sequencing and Histologic Findings YONSEI MEDICAL JOURNAL
2024Elasticity Values as a Predictive Modality for Response to Neoadjuvant Chemotherapy in Breast Cancer CANCERS
2024Second-line chemoimmunotherapy with nivolumab and paclitaxel in immune-related biomarker-enriched advanced gastric cancer: a multicenter phase Ib/II studyGASTRIC CANCER
2024Open-Label, Multicenter, Randomized, Biomarker-Integrated Umbrella Trial for Second-Line Treatment of Advanced Gastric Cancer: K-Umbrella Gastric Cancer StudyJOURNAL OF CLINICAL ONCOLOGY
2024Deciphering the Role of ERBB3 Isoforms in Renal Cell Carcinoma: A Comprehensive Genomic and Transcriptomic Analysis MEDICINA-LITHUANIA
2024PD-1 inhibitor plus oncolytic vaccinia virus is a safe and effective treatment option for metastatic renal cell carcinoma CANCER CELL INTERNATIONAL
2024C4d Puzzle in ABO-incompatible kidney transplantation KIDNEY RESEARCH AND CLINICAL PRACTICE
2024Neoadjuvant and Adjuvant Osimertinib in Stage IA to IIIA, EGFR-Mutant NSCLC (NORA) JOURNAL OF THORACIC ONCOLOGY
2024Predictive Value of the nProfiler 1 Assay for the Efficacy of Adjuvant S-1-Based Doublet Chemotherapy in Stage III Gastric Cancer: A Post-Hoc Analysis of a Randomized Phase III Trial CANCER RESEARCH AND TREATMENT
2023Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab-bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective studyLANCET ONCOLOGY
2023A Case of Gastric Mixed Neuroendocrine-Nonneuroendocrine Neoplasm Composed With Adenoma and Neuroendocrine Tumor Korean Journal of Helicobacter and Upper Gastrointestinal Research
2023Creeping fat exhibits distinct Inflammation-specific adipogenic preadipocytes in Crohn's disease FRONTIERS IN IMMUNOLOGY
2023Randomized, two-arm, noncomparative phase 2 study of olaparib plus cediranib or durvalumab in HRR-mutated, platinum-resistant ovarian cancer: A substudy of KGOG 3045INTERNATIONAL JOURNAL OF CANCER
2023The 2021 WHO Classification for Gliomas and Implications on Imaging Diagnosis: Part 3-Summary of Imaging Findings on Glioneuronal and Neuronal TumorsJOURNAL OF MAGNETIC RESONANCE IMAGING
1234567891011 172
  • License
    sherpa_romeo
    sherpa_juliet

OAK

DSpace Software Copyright © 2002-2017 Duraspace Yonsei University Medical Library All right Reserves. / TEL:02-2228-2915 /
YUHSpace는 국립중앙도서관 OAK 보급사업으로 구축되었습니다.

Browse

Links